Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 155

1.

Healthcare-associated urinary tract infections with onset post hospital discharge.

Elman MR, Williams CD, Bearden DT, Townes JM, Heintzman JD, Lapidus JA, Kullar R, Markwardt S, Trieu AT, Vahidi AA, McGregor JC.

Infect Control Hosp Epidemiol. 2019 Aug;40(8):863-871. doi: 10.1017/ice.2019.148. Epub 2019 Jun 20.

PMID:
31217038
2.

Assessment of the Appropriateness of Antibiotic Prescriptions for Infection Prophylaxis Before Dental Procedures, 2011 to 2015.

Suda KJ, Calip GS, Zhou J, Rowan S, Gross AE, Hershow RC, Perez RI, McGregor JC, Evans CT.

JAMA Netw Open. 2019 May 3;2(5):e193909. doi: 10.1001/jamanetworkopen.2019.3909.

3.

In vitro mechanical behavior and in vivo healing response of a novel thin-strut ultrahigh molecular weight poly-l-lactic acid sirolimus-eluting bioresorbable coronary scaffold in normal swine.

Cheng Y, Gasior P, Ramzipoor K, Lee C, McGregor JC, Conditt GB, McAndrew T, Kaluza GL, Granada JF.

Int J Cardiol. 2019 Jul 1;286:21-28. doi: 10.1016/j.ijcard.2019.04.012. Epub 2019 Apr 4.

PMID:
30967275
4.

Frequency and Documentation of Medication Decisions on Discharge from the Hospital to Hospice Care.

Kadoyama KL, Noble BN, Izumi S, Fromme EK, Tjia J, McPherson ML, Candrian CB, McGregor JC, Ku IY, Furuno JP.

J Am Geriatr Soc. 2019 Jun;67(6):1258-1262. doi: 10.1111/jgs.15860. Epub 2019 Mar 10.

PMID:
30854629
5.

Antibiotic prescribing upon discharge from the hospital to long-term care facilities: Implications for antimicrobial stewardship requirements in post-acute settings.

Weber BR, Noble BN, Bearden DT, Crnich CJ, Ellingson KD, McGregor JC, Furuno JP.

Infect Control Hosp Epidemiol. 2019 Jan;40(1):18-23. doi: 10.1017/ice.2018.288. Epub 2018 Nov 9.

PMID:
30409235
6.

Two-year longitudinal evaluation of a second-generation thin-strut sirolimus-eluting bioresorbable coronary scaffold with hybrid cell design in porcine coronary arteries.

Gasior P, Cheng Y, Xia J, Conditt GB, McGregor JC, Virmani R, Granada JF, Kaluza GL.

Cardiol J. 2018 Aug 29. doi: 10.5603/CJ.a2018.0095. [Epub ahead of print]

7.

Clinical Outcomes of Oral Suspension versus Delayed-Release Tablet Formulations of Posaconazole for Prophylaxis of Invasive Fungal Infections.

Furuno JP, Tallman GB, Noble BN, Bubalo JS, Forrest GN, Lewis JS 2nd, Bienvenida AF, Holmes CA, Weber BR, McGregor JC.

Antimicrob Agents Chemother. 2018 Sep 24;62(10). pii: e00893-18. doi: 10.1128/AAC.00893-18. Print 2018 Oct.

8.

Empiric Antibiotic Prescribing Decisions Among Medical Residents: The Role of the Antibiogram.

Tallman GB, Vilches-Tran RA, Elman MR, Bearden DT, Taylor JE, Gorman PN, McGregor JC.

Infect Control Hosp Epidemiol. 2018 May;39(5):578-583. doi: 10.1017/ice.2018.28. Epub 2018 Mar 1.

PMID:
29493481
9.

Comparative Biomechanical Behavior and Healing Profile of a Novel Thinned Wall Ultrahigh Molecular Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.

Cheng Y, Gasior P, Xia JG, Ramzipoor K, Lee C, Estrada EA, Dokko D, McGregor JC, Conditt GB, McAndrew T, Kaluza GL, Granada JF.

Circ Cardiovasc Interv. 2017 Jul;10(7). pii: e005116. doi: 10.1161/CIRCINTERVENTIONS.117.005116.

PMID:
28701488
10.

Comparative Characterization of Biomechanical Behavior and Healing Profile of a Novel Ultra-High-Molecular-Weight Amorphous Poly-l-Lactic Acid Sirolimus-Eluting Bioresorbable Coronary Scaffold.

Cheng Y, Gasior P, Shibuya M, Ramzipoor K, Lee C, Estrada EA, Dokko D, McGregor JC, Conditt GB, Kaluza GL, Granada JF.

Circ Cardiovasc Interv. 2016 Oct;9(10). pii: e004253.

PMID:
27694138
11.

Antibiotic Policies and Utilization in Oregon Hospice Programs.

Novak RL, Noble BN, Fromme EK, Tice MO, McGregor JC, Furuno JP.

Am J Hosp Palliat Care. 2016 Sep;33(8):777-81. doi: 10.1177/1049909115599951. Epub 2015 Aug 12.

PMID:
26268730
12.

Aspirin use among adults in the U.S.: results of a national survey.

Williams CD, Chan AT, Elman MR, Kristensen AH, Miser WF, Pignone MP, Stafford RS, McGregor JC.

Am J Prev Med. 2015 May;48(5):501-8. doi: 10.1016/j.amepre.2014.11.005.

PMID:
25891049
13.

Vessel Caging Versus Vascular Restoration in the Same Artery: Long-Term Vascular Remodeling and Healing in Response to Overlapping Metal Stent and Bioresorbable Polymer Scaffold.

Gongora CA, Shibuya M, Ramzipoor K, Lee C, Cheng Y, McGregor JC, Estrada EA, Granada JF, Kaluza GL.

JACC Cardiovasc Interv. 2015 Apr 20;8(4):631-2. doi: 10.1016/j.jcin.2014.10.028. Epub 2015 Mar 26. No abstract available.

14.

Evaluation of collaborative therapy review to improve care of heart failure patients.

Singh H, McGregor JC, Nigro SJ, Higginson A, Larsen GC.

Am J Manag Care. 2014 Oct 1;20(10):e425-31.

15.

Optimizing research methods used for the evaluation of antimicrobial stewardship programs.

McGregor JC, Furuno JP.

Clin Infect Dis. 2014 Oct 15;59 Suppl 3:S185-92. doi: 10.1093/cid/ciu540.

PMID:
25261546
16.

Peri-strut low-intensity areas in optical coherence tomography correlate with peri-strut inflammation and neointimal proliferation: an in-vivo correlation study in the familial hypercholesterolemic coronary swine model of in-stent restenosis.

Tellez A, Afari ME, Buszman PP, Seifert P, Cheng Y, Milewski K, McGregor JC, Garza JA, Roberts MB, Yi GH, Kaluza GL, Granada JF.

Coron Artery Dis. 2014 Nov;25(7):595-601. doi: 10.1097/MCA.0000000000000134.

PMID:
25013949
17.

Frequency of outpatient antibiotic prescription on discharge to hospice care.

Furuno JP, Noble BN, Horne KN, McGregor JC, Elman MR, Bearden DT, Walsh EW, Fromme EK.

Antimicrob Agents Chemother. 2014 Sep;58(9):5473-7. doi: 10.1128/AAC.02873-14. Epub 2014 Jul 7.

18.

The need for advancements in the field of risk adjustment for healthcare-associated infections.

McGregor JC, Harris AD.

Infect Control Hosp Epidemiol. 2014 Jan;35(1):8-9. doi: 10.1086/674412. Epub 2013 Nov 26. No abstract available.

PMID:
24334791
19.

Antimicrobial use for symptom management in patients receiving hospice and palliative care: a systematic review.

Rosenberg JH, Albrecht JS, Fromme EK, Noble BN, McGregor JC, Comer AC, Furuno JP.

J Palliat Med. 2013 Dec;16(12):1568-74. doi: 10.1089/jpm.2013.0276. Epub 2013 Oct 23. Review.

20.

Variation in antibiotic susceptibility of uropathogens by age among ambulatory pediatric patients.

McGregor JC, Quach Y, Bearden DT, Smith DH, Sharp SE, Guzman-Cottrill JA.

J Pediatr Nurs. 2014 Mar-Apr;29(2):152-7. doi: 10.1016/j.pedn.2013.09.001. Epub 2013 Sep 30.

21.

Tissue uptake, distribution, and healing response after delivery of paclitaxel via second-generation iopromide-based balloon coating: a comparison with the first-generation technology in the iliofemoral porcine model.

Buszman PP, Tellez A, Afari ME, Peppas A, Conditt GB, Rousselle SD, McGregor JC, Stenoien M, Kaluza GL, Granada JF.

JACC Cardiovasc Interv. 2013 Aug;6(8):883-90. doi: 10.1016/j.jcin.2013.04.013.

22.

Stent healing response following delivery of paclitaxel via durable polymeric matrix versus iopromide-based balloon coating in the familial hypercholesterolaemic swine model of coronary injury.

Buszman PP, Tellez A, Afari M, Cheng Y, Conditt GB, McGregor JC, Milewski K, Stenoien M, Kaluza GL, Granada JF.

EuroIntervention. 2013 Aug 22;9(4):510-6. doi: 10.4244/EIJV9I4A82.

23.

Quality of hospice care for individuals with dementia.

Albrecht JS, Gruber-Baldini AL, Fromme EK, McGregor JC, Lee DS, Furuno JP.

J Am Geriatr Soc. 2013 Jul;61(7):1060-5. doi: 10.1111/jgs.12316. Epub 2013 May 27.

24.

Use of electronic health record data to identify skin and soft tissue infections in primary care settings: a validation study.

Levine PJ, Elman MR, Kullar R, Townes JM, Bearden DT, Vilches-Tran R, McClellan I, McGregor JC.

BMC Infect Dis. 2013 Apr 10;13:171. doi: 10.1186/1471-2334-13-171.

25.

Risk of acquiring extended-spectrum β-lactamase-producing Klebsiella species and Escherichia coli from prior room occupants in the intensive care unit.

Ajao AO, Johnson JK, Harris AD, Zhan M, McGregor JC, Thom KA, Furuno JP.

Infect Control Hosp Epidemiol. 2013 May;34(5):453-8. doi: 10.1086/670216.

26.

Comparison of antibiograms developed for inpatients and primary care outpatients.

McGregor JC, Bearden DT, Townes JM, Sharp SE, Gorman PN, Elman MR, Mori M, Smith DH.

Diagn Microbiol Infect Dis. 2013 May;76(1):73-9. doi: 10.1016/j.diagmicrobio.2013.01.026. Epub 2013 Mar 27.

27.

Sex- and age-specific trends in antibiotic resistance patterns of Escherichia coli urinary isolates from outpatients.

McGregor JC, Elman MR, Bearden DT, Smith DH.

BMC Fam Pract. 2013 Feb 22;14:25. doi: 10.1186/1471-2296-14-25.

28.

A nationwide analysis of antibiotic use in hospice care in the final week of life.

Albrecht JS, McGregor JC, Fromme EK, Bearden DT, Furuno JP.

J Pain Symptom Manage. 2013 Oct;46(4):483-90. doi: 10.1016/j.jpainsymman.2012.09.010. Epub 2013 Jan 11.

29.

Evaluation of efficacy and dose response of different paclitaxel-coated balloon formulations in a novel swine model of iliofemoral in-stent restenosis.

Milewski K, Afari ME, Tellez A, Aboodi MS, Kim JS, Cheng Y, Conditt GB, McGregor JC, Yi GH, Stenoien M, Langanki D, Krueger CG, Kaluza GL, Granada JF.

JACC Cardiovasc Interv. 2012 Oct;5(10):1081-8. doi: 10.1016/j.jcin.2012.06.012.

30.

Generic substitution of lamotrigine among medicaid patients with diverse indications: a cohort-crossover study.

Hartung DM, Middleton L, Svoboda L, McGregor JC.

CNS Drugs. 2012 Aug 1;26(8):707-16. doi: 10.2165/11634260-000000000-00000.

31.

Risk factors associated with linezolid-nonsusceptible enterococcal infections.

McGregor JC, Hartung DM, Allen GP, Taplitz RA, Traver R, Tong T, Bearden DT.

Am J Infect Control. 2012 Nov;40(9):886-7. doi: 10.1016/j.ajic.2011.11.005. Epub 2012 Feb 22.

32.

Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia.

Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Cosgrove SE, Sakoulas G, Perencevich EN.

BMC Infect Dis. 2011 Oct 19;11:279. doi: 10.1186/1471-2334-11-279.

33.

Paclitaxel-iopromide coated balloon followed by "bail-out" bare metal stent in porcine iliofemoral arteries: first report on biological effects in peripheral circulation.

Milewski K, Tellez A, Aboodi MS, Conditt GB, Yi GH, Thim T, Stenoien M, McGregor JC, Gray WA, Virmani R, Granada JF, Kaluza GL.

EuroIntervention. 2011 Jul;7(3):362-8. doi: 10.4244/EIJV7I3A61.

34.

Risk factors for development of intestinal colonization with imipenem-resistant Pseudomonas aeruginosa in the intensive care unit setting.

Harris AD, Johnson JK, Thom KA, Morgan DJ, McGregor JC, Ajao AO, Moore AC, Comer AC, Furuno JP.

Infect Control Hosp Epidemiol. 2011 Jul;32(7):719-22. doi: 10.1086/660763.

35.

Systematic review of measurement and adjustment for colonization pressure in studies of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, and clostridium difficile acquisition.

Ajao AO, Harris AD, Roghmann MC, Johnson JK, Zhan M, McGregor JC, Furuno JP.

Infect Control Hosp Epidemiol. 2011 May;32(5):481-9. doi: 10.1086/659403. Review.

36.

Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients.

Schweizer ML, Furuno JP, Sakoulas G, Johnson JK, Harris AD, Shardell MD, McGregor JC, Thom KA, Perencevich EN.

Antimicrob Agents Chemother. 2011 Mar;55(3):1082-7. doi: 10.1128/AAC.00918-10. Epub 2010 Dec 20.

37.

Coronary bare metal stent implantation in homozygous LDL receptor deficient swine induces a neointimal formation pattern similar to humans.

Tellez A, Krueger CG, Seifert P, Winsor-Hines D, Piedrahita C, Cheng Y, Milewski K, Aboodi MS, Yi G, McGregor JC, Crenshaw T, Reed JD, Huibregtse B, Kaluza GL, Granada JF.

Atherosclerosis. 2010 Dec;213(2):518-24. doi: 10.1016/j.atherosclerosis.2010.09.021. Epub 2010 Sep 25.

PMID:
20950808
38.

Empiric antibiotic therapy for Staphylococcus aureus bacteremia may not reduce in-hospital mortality: a retrospective cohort study.

Schweizer ML, Furuno JP, Harris AD, Johnson JK, Shardell MD, McGregor JC, Thom KA, Sakoulas G, Perencevich EN.

PLoS One. 2010 Jul 2;5(7):e11432. doi: 10.1371/journal.pone.0011432.

39.

An alternative model for teaching basic principles and surgical skills in plastic surgery.

Whallett EJ, McGregor JC.

J Plast Reconstr Aesthet Surg. 2011 Feb;64(2):272-4. doi: 10.1016/j.bjps.2010.06.017. No abstract available.

PMID:
20619757
40.

In vivo intravascular ultrasound analysis of the absorption rate of the Angio-Seal vascular closure device in the porcine femoral artery.

Tellez A, Cheng Y, Yi GH, Conditt GB, McGregor JC, Flynn AM, Ordanes D, Mintz GS, Kaluza GL, Granada JF.

EuroIntervention. 2010 Jan;5(6):731-6.

PMID:
20142226
41.

Prevalence of antimicrobial-resistant bacteria isolated from older versus younger hospitalized adults: results of a two-centre study.

Weber SG, Miller RR, Perencevich EN, Tolentino J, Meltzer D, Pitrak D, McGregor JC, Sachs GA, Harris AD, Furuno JP.

J Antimicrob Chemother. 2009 Dec;64(6):1291-8. doi: 10.1093/jac/dkp349. Epub 2009 Sep 24.

42.

Usefulness of antibiogram surveillance for methicillin-resistant Staphylococcus aureus in outpatient pediatric populations.

McGregor JC, Dumyati G, Casiano-Colón AE, Chang PJ, Klevens RM.

Diagn Microbiol Infect Dis. 2009 May;64(1):70-5. doi: 10.1016/j.diagmicrobio.2008.12.016. Epub 2009 Feb 26.

PMID:
19249172
43.

Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis.

McGregor JC, Allen GP, Bearden DT.

Ther Clin Risk Manag. 2008 Oct;4(5):843-53.

44.

A plastic surgeon retires--due to illness.

McGregor JC.

J Plast Reconstr Aesthet Surg. 2009 Jan;62(1):1-4. No abstract available.

PMID:
19112648
45.

Summer Peaks in the Incidences of Gram-Negative Bacterial Infection Among Hospitalized Patients.

Perencevich EN, McGregor JC, Shardell M, Furuno JP, Harris AD, Morris JG Jr, Fisman DN, Johnson JA.

Infect Control Hosp Epidemiol. 2008 Dec;29(12):1124-31.

PMID:
19031546
46.

Controlling for severity of illness in outcome studies involving infectious diseases: impact of measurement at different time points.

Thom KA, Shardell MD, Osih RB, Schweizer ML, Furuno JP, Perencevich EN, McGregor JC, Harris AD.

Infect Control Hosp Epidemiol. 2008 Nov;29(11):1048-53. doi: 10.1086/591453.

47.

Impact of empiric antimicrobial therapy on outcomes in patients with Escherichia coli and Klebsiella pneumoniae bacteremia: a cohort study.

Thom KA, Schweizer ML, Osih RB, McGregor JC, Furuno JP, Perencevich EN, Harris AD.

BMC Infect Dis. 2008 Sep 15;8:116. doi: 10.1186/1471-2334-8-116.

48.

Clinical utility of infection control documentation of prior methicillin-resistant Staphylococcus aureus colonization or infection for optimization of empirical antibiotic therapy.

Schweizer ML, Furuno JP, Harris AD, McGregor JC, Thom KA, Johnson JK, Shardell MD, Perencevich EN.

Infect Control Hosp Epidemiol. 2008 Oct;29(10):972-4. doi: 10.1086/590665.

49.

The importance of case-mix adjustment for infection rates and the need for more research.

Harris AD, McGregor JC.

Infect Control Hosp Epidemiol. 2008 Aug;29(8):693-4. doi: 10.1086/590471. No abstract available.

PMID:
18643745
50.

Labial surgery--a new phenomenon?

McGregor JC.

J Plast Reconstr Aesthet Surg. 2009 Mar;62(3):289. doi: 10.1016/j.bjps.2008.01.044. Epub 2008 Jul 21. No abstract available.

PMID:
18640888

Supplemental Content

Loading ...
Support Center